This episode focuses on the crucial role of biomarkers in Phase 2 clinical trials. Biomarkers, which are measurable indicators of biological processes or drug responses, are used to monitor drug response, predict clinical efficacy, and guide treatment decisions. We discuss various types of biomarkers, including those measuring protein levels, genetic signatures, and changes in physiological parameters like blood pressure. The episode emphasizes the importance of validating biomarkers, ensuring their accuracy, sensitivity, specificity, and reproducibility. Real-world examples are used to illustrate how biomarkers are integrated into trial design, including their use in determining optimal dose ranges and selecting appropriate patient populations.

Furthermore, the episode explores the regulatory context surrounding the use of biomarkers in cl ...